DrugSupplement
Black cumin clinical trials
Also written Nigella sativa seed.
- studies test it
- 4
- open now
- 0
- in phase 3
- 2
- first study started
- 2006
How studies write it
Studies that test it under each name
Other names
Combined with it in one product
Studies by the year they started
4 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 3
Sohaib Ashraf (2) · Supplement Formulators, Inc. (1) · Aga Khan University (1)
Often tested with
Tested in the same studies.
Honey (2) · Nigella sativa (1) · Turmeric extract (1) · Curcuma longa (1)
Studies
Open first, then newest update. How each study uses black cumin is read from its arms, and is right about nine times in ten.
Testing it · 4
- Honey and Nigella Sativa in COVID-19 ProphylaxisStatus unknownPhase 2/3Sohaib AshrafNCT04767087Written as Nigella sativa seed
- Honey & Nigella Sativa Trial Against COVID-19CompletedPhase 3Sohaib AshrafNCT04347382Written as Nigella Sativa / Black Cumin
- A Study to Evaluate the Effects of a Turmeric and Black Cumin Seed Formulation on Cholesterol LevelsCompletedNot applicableSupplement Formulators, Inc.NCT03175757Written as Turmeric and Black Cumin Seed
- Effectiveness of Nigella Sativa (Kalonji) Seed in DyslipidemiaCompletedPhase 1/2Aga Khan UniversityNCT00327054Written as Nigella sativa seed
Codes
What other systems call black cumin · ClinicalTrials.gg INT014897
- RxNorm 1808612One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 1808612 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.